Dragan Cicic serves as Executive at Actinium Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Dragan Cicic has executed 5 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 7, 2026 involved receiving (via award) 300,000 shares valued at $0.
Dragan Cicic currently holds 557,805 shares of Actinium Pharmaceuticals, Inc. (ATNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Dragan Cicic has been a net neutral trader of ATNM stock. They have purchased $0 and sold $0 worth of shares.
Dragan Cicic's most recent insider trade was on Jan 7, 2026, when they sold 300,000 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $1.50 |
| Discretionary |
| May 7, 2015 | ATNM | $1.4K | Payment | 560 | $2.52 | Discretionary |
| May 7, 2015 | ATNM | $6.0K | Disposition | 2,380 | $2.52 | Discretionary |
| Feb 21, 2014 | ATNM | $19.4K | Award | 3,500 | $5.55 | Discretionary |